Updates are available Correction dated 2021-04-26
Click to view Correction: https://doi.org/10.1038/s41590-021-00929-x
Updates are available Correction dated 2020-11-19
Click to view Correction: https://doi.org/10.1038/s41590-020-00841-w
-
Authors
Harb, Hani http://orcid.org/0000-0001-8218-2538
Stephen-Victor, Emmanuel
Crestani, Elena
Benamar, Mehdi
Massoud, Amir
Cui, Ye
Charbonnier, Louis-Marie http://orcid.org/0000-0002-4594-7893
Arbag, Sena
Baris, Safa http://orcid.org/0000-0002-4730-9422
Cunnigham, Amparito
Leyva-Castillo, Juan Manuel
Geha, Raif S.
Mousavi, Amirhosein J.
Guennewig, Boris
Schmitz-Abe, Klaus
Sioutas, Constantinos
Phipatanakul, Wanda
Chatila, Talal A. http://orcid.org/0000-0001-7439-2762
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI115699, AI065617)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI065617)
Deutsche Forschungsgemeinschaft (HA 8465/1-1)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI110397)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL137192)
- License Information
-
More Information
Article History
Received: 9 March 2020
Accepted: 5 August 2020
First Online: 14 September 2020
Change Date: 19 November 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-020-00841-w
Change Date: 26 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-021-00929-x
Competing interests
: T.A.C., H.H. and A.M. are inventors on published US patent application no. WO2019178488A1 submitted by the Children’s Medical Center Corporation, titled ‘Method for treating asthma or allergic disease’. B.G. is a director of Pacific Analytics and SMRTR, Australia; a founding member of the International Cerebral Palsy Genetics Consortium; and a member of the Australian Genomics Health Alliance. W.P. is a Consultant for Genentech, Novartis, Regeneron, Sanofi Genzyme and Glaxo Smith Kline, and receives clinical trial support from Genentech, Novartis, Regeneron, Circassia, Thermo Fisher, Monaghan, Lincoln Diagnostics, Alk Abello and Glaxo Smith Kline.
